Go to the stock screener
Drug Manufacturers (General) stocks
Astellas Pharma has the highest MEQIRI Score in Drug Manufacturers (General) today at 87. 17 of 27 companies are Strong.
All 27 Drug Manufacturers (General) stocks at MEQIRI, largest first.
As of 12 Nov 2026. How the score is calculated
Companies
27
With score
27
Average score
71
Median P/E
23.4
Median dividend
2.1%
| No. | Stock | Score | Crash risk | P/E | Dividend | Market cap |
|---|---|---|---|---|---|---|
| 1 | Eli LillyLLY | 85 | medium | 46.6 | 0.5% | $1.35T |
| 2 | Johnson & JohnsonJNJ | 75 | low | 42.7 | 1.9% | $675.03B |
| 3 | AbbVieABBV | 75 | low | 50.5 | 2.4% | $521.41B |
| 4 | Roche HoldingROP.SW | 77 | low | 26.4 | 2.4% | $391.92B |
| 5 | MerckMRK | 68 | low | 148.7*forward 18.2 | 2.3% | $362.86B |
| 6 | NovartisNOVN.SW | 76 | low | 30.7 | 2.8% | $302.09B |
| 7 | AstraZenecaAZN | 73 | medium | 26.3 | 1.7% | $287.66B |
| 8 | AmgenAMGN | 77 | low | 27.2 | 2.1% | $253.21B |
| 9 | Gilead SciencesGILD | 58 | low | Loss | 1.9% | $210.52B |
| 10 | Novo NordiskNOVO-B.CO | 79 | high | 10.7 | 4.3% | $178.97B |
| 11 | PfizerPFE | 61 | low | 41.9*forward 10.0 | 5.8% | $167.86B |
| 12 | Bristol-Myers SquibbBMY | 71 | low | 14.0 | 4.0% | $128.59B |
| 13 | SanofiSAN.PA | 67 | low | 25.1*adjusted 11.4 | 4.8% | $115.46B |
| 14 | GSKGSK | 70 | low | 17.9 | 3.6% | $101.43B |
| 15 | Chugai Pharmaceutical4519.T | 78 | 23.4 | 0.9% | $73.85B | |
| 16 | BayerBAYN.DE | 53 | medium | Loss | 0.2% | $62.05B |
| 17 | Otsuka Holdings4578.T | 78 | 16.3 | 1.4% | $39.66B | |
| 18 | BiogenBIIB | 60 | low | 107.6*forward 16.1 | 0.0% | $37.46B |
| 19 | Daiichi Sankyo4568.T | 71 | 18.2 | 3.2% | $31.7B | |
| 20 | Astellas Pharma4503.T | 87 | 12.3 | 3.0% | $29.67B | |
| 21 | OrionORNBV.HE | 86 | medium | 22.0 | 1.8% | $16.06B |
| 22 | CSPC Pharmaceutical Group1093.HK | 79 | 11.3 | 3.9% | $12.4B | |
| 23 | Zhangzhou Pientzehuang Pharmaceutical.600436.SS | 58 | 59.7*adjusted 42.5 | 2.0% | $11.78B | |
| 24 | GrifolsGRF.MC | 66 | low | 16.0 | 0.7% | $8.69B |
| 25 | Ono Pharmaceutical4528.T | 73 | 15.3 | 3.3% | $7.16B | |
| 26 | OrganonOGN | 59 | medium | 17.8*adjusted 4.9 | 0.6% | $3.65B |
| 27 | VirbacVIRP.PA | 68 | low | 19.3 | 0.4% | $3.34B |
* P/E with one-off items or after a one-time drop in earnings. Below it is the adjusted or the forward P/E. The P/E then does not count in the score.